SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-19-101691
Filing Date
2019-04-09
Accepted
2019-04-09 16:15:51
Documents
6
Period of Report
2019-06-11

Document Format Files

Seq Description Document Type Size
1 PRE 14A d660374dpre14a.htm PRE 14A 997551
2 GRAPHIC g660374g21w10.jpg GRAPHIC 33374
3 GRAPHIC g660374g38l86.jpg GRAPHIC 23213
4 GRAPHIC g660374g47k82.jpg GRAPHIC 25755
5 GRAPHIC g660374g54t09.jpg GRAPHIC 22635
6 GRAPHIC g660374g77a13.jpg GRAPHIC 23954
  Complete submission text file 0001193125-19-101691.txt   1176210
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37923 | Film No.: 19739643
SIC: 2836 Biological Products, (No Diagnostic Substances)